These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22314198)

  • 1. Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease.
    Jean G; Souberbielle JC; Zaoui E; Lorriaux C; Mayor B; Hurot JM; Deleaval P; Chazot C
    Clin Biochem; 2012 Apr; 45(6):436-9. PubMed ID: 22314198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
    Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
    Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?
    Delanaye P; Dubois BE; Jouret F; Krzesinski JM; Moranne O; Cavalier E
    Clin Chim Acta; 2013 Feb; 417():35-8. PubMed ID: 23262367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients.
    Couttenye MM; D'Haese PC; Van Hoof VO; Lemoniatou E; Goodman W; Verpooten GA; De Broe ME
    Nephrol Dial Transplant; 1996 Jun; 11(6):1065-72. PubMed ID: 8671970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
    Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients.
    Takahashi N; Kojima T; Ogawa H; Ishiguro N
    Nephrology (Carlton); 2007 Dec; 12(6):539-45. PubMed ID: 17995578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The source and clinical significance of serum alkaline phosphatases in patients treated by chronic dialysis.
    Stĕpán J; Pilarová T; Melicharová D
    Acta Univ Carol Med Monogr; 1977; (78 Pt 2):75-9. PubMed ID: 615470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.
    Milinković NL; Majkic-Singh NT; Ignjatović SD; Lezaić VD; Pejanović SD; Jovanovic DB
    Clin Lab; 2012; 58(7-8):747-53. PubMed ID: 22997975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort.
    Jean G; Lataillade D; Genet L; Legrand E; Kuentz F; Moreau-Gaudry X; Fouque D;
    Nephron Clin Pract; 2011; 118(2):c211-6. PubMed ID: 21178378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of the results of the Sr85 test and of bone alkaline phosphatase isoenzyme activity].
    Stĕpán J; Kolár J; Stĕpán J; Susta A
    Z Rheumatol; 1977; 36(3-4):120-5. PubMed ID: 871069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
    Inaba M; Nagasue K; Okuno S; Ueda M; Kumeda Y; Imanishi Y; Shoji T; Ishimura E; Ohta T; Nakatani T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Jun; 39(6):1261-9. PubMed ID: 12046040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between bone mineral density and secondary hyperparathyroidism bone disease].
    Ning JP; Sun M; Toru I; Etsuo Y
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):77-9. PubMed ID: 12212259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():190-2. PubMed ID: 15631341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.